Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR
2010 · New England Journal of Medicine · 5,521 citations
https://doi.org/10.1056/nejmoa0909530
A
Akihiko Gemma
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
663
Papers
18.4K
Citations
55
h-index
214
i10-index
Akihiko Gemma is an academic researcher from Nippon Medical School. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Lung Cancer Research Studies & Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis. The author has an h-index of 55, co-authored 564 publications.
ORCID: 0000-0003-0762-2737Papers by this author
worksPirfenidone inhibits fibrocyte accumulation in the lungs in bleomycin-induced murine pulmonary fibrosis
2014 · Respiratory Research · 119 citations
https://doi.org/10.1186/1465-9921-15-16
Diagnosis and management of drug-associated interstitial lung disease
2004 · British Journal of Cancer · 105 citations
https://doi.org/10.1038/sj.bjc.6602064
Gefitinib (IRESSA) sensitive lung cancer cell lines show phosphorylation of Akt without ligand stimulation
2006 · BMC Cancer · 66 citations
https://doi.org/10.1186/1471-2407-6-277
Evaluation of Right Ventricular Function in Patients With COPD
2012 · Respiratory Care · 65 citations
https://doi.org/10.4187/respcare.01856
Ankyrin Repeat Domain 1 Overexpression is Associated with Common Resistance to Afatinib and Osimertinib in EGFR-mutant Lung Cancer
2018 · Scientific Reports · 55 citations
https://doi.org/10.1038/s41598-018-33190-8
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat